Olema Pharmaceuticals (OLMA) Revenue & Revenue Breakdown
Olema Pharmaceuticals Revenue Highlights
00
Olema Pharmaceuticals Revenue by Period
Olema Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Olema Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.88M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | - |
Olema Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
FENC | Fennec Pharmaceuticals | $21.64M | $6.97M |
MOLN | Molecular Partners | $7.04M | $2.74M |
CNTA | Centessa Pharmaceuticals | $6.88M | - |
OBIO | Orchestra BioMed | $2.76M | $778.00K |
LIFE | aTyr Pharma | $353.00K | $235.00K |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
ANTX | AN2 Therapeutics | - | - |
GRCL | Gracell Bio | - | - |
PHVS | Pharvaris | - | - |
IRON | Disc Medicine | - | - |
OLMA | Olema Pharmaceuticals | - | - |
ERAS | Erasca | - | - |
MLYS | Mineralys Therapeutics | - | - |
LRMR | Larimar Therapeutics | - | - |
SANA | Sana Bio | - | - |
NVCT | Nuvectis Pharma | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
ZNTL | Zentalis Pharmaceuticals | - | - |
PEPG | PepGen | - | - |